Name: After Exporting 60 million Doses, India Stops Vaccine Export Amid Fresh Covid-19 Spike
Uploaded: 2021-03-25T20:05:35+05:30
Description: The move will also affect supplies to the GAVI/WHO-backed global COVAX vaccine-sharing facility.

Commonwealth Games

Netra Suraksh

&nbsp;

#CommonwealthGames2022

#IndvsWI

Live Blog

India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world’s biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters. 
The move will also affect supplies to the GAVI/WHO-backed global COVAX vaccine-sharing facility, through which 64 lower-income countries are supposed to get doses from SII, the programme’s procurement and distributing partner UNICEF said.
Read all the <a href="https://www.news18.com/news/">Latest News</a>, <a href="https://www.news18.com/">Breaking News</a> and <a href="https://www.news18.com/news/india/coronavirus-live-updates-active-cases-dip-below-3l-lowest-in-6-months-karnataka-reserves-beds-for-kids-4239641.html">Coronavirus News</a> here

After Exporting 60 million Doses, India Stops Vaccine Export Amid Fresh Covid-19 Spike

iVideos

India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world’s biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters.

Adar Poonawalla covishield

bharat biotech covaxin

COVAX

COVAX Facility

Covax Gavi

After Exporting 60 million Doses, India Stops Vaccine Export Amid Fresh Covid-19 Spike

TRENDING VIDEOS

TRENDING PHOTOS